Vanta Bioscience is currently trading at Rs. 82.25, up by 1.25 points or 1.54% from its previous closing of Rs. 81.00 on the BSE.
The scrip opened at Rs. 85.00 and has touched a high and low of Rs. 88.10 and Rs. 82.25 respectively. So far 12000 shares were traded on the counter.
The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 88.10 on 30-Jul-2018 and a 52 week low of Rs. 41.40 on 12-Oct-2017.
Last one week high and low of the scrip stood at Rs. 88.10 and Rs. 70.10 respectively. The current market cap of the company is Rs. 47.11 crore.
The promoters holding in the company stood at 72.45%, while Non-Institutions held 27.55%.
Vanta Bioscience has forayed into Clinical Research through a 100% subsidiary. The clinical research business will begin contributing to the top-line in the last quarter of the current financial year.
The company is projecting to add revenue of Rs 250 crore in the fifth year through clinical research services. Major activities covered under the clinical services include bio-equivalence studies in healthy human volunteers, patient volunteers, bioanalytical services and clinical trials from Phase I to Phase IV.
Vanta Bioscience is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
Company Name | CMP |
---|---|
Syngene Internation. | 915.70 |
Sagility India | 34.94 |
AGS Transact Tech | 79.93 |
Just Dial | 1119.55 |
Krystal Integrated | 769.90 |
View more.. |